OTCMKTS:NXEN

Nexien BioPharma Stock Forecast, Price & News

$0.19

-0.04 (-17.78 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.17

Now: $0.19▼

$0.24

50-Day Range

$0.08

MA: $0.13▼

$0.22

52-Week Range

$0.01

Now: $0.19▼

$0.45

Volume7,323 shs

Average Volume46,998 shs

Market Capitalization$10.35 million

P/E RatioN/A

Dividend YieldN/A

Beta-701.47

Nexien BioPharma, a pharmaceutical company, engages in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways to address a range of medical conditions and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Headlines

Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
February 19, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:NXEN

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.nexienbiopharma.com

Phone303-495-7583

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio0.70

Quick Ratio0.70

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-2,670,000.00

Net MarginsN/A

Return on Equity-16,049.80%

Return on Assets-6,651.95%

Miscellaneous

Outstanding Shares55,931,000

Market Cap$10.35 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1885th out of 1,969 stocks

Pharmaceutical Preparations Industry

749th out of 771 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Nexien BioPharma.

0.0 Community Rank

Outperform Votes
Nexien BioPharma has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Nexien BioPharma has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Nexien BioPharma and other stocks. Vote “Outperform” if you believe NXEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NXEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Nexien BioPharma does not currently pay a dividend.
Dividend Growth
Nexien BioPharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nexien BioPharma insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 30.60% of the stock of Nexien BioPharma is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.19

-0.04 (-17.78 %)

(As of 03/5/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive NXEN News and Ratings via Email

Sign-up to receive the latest news and ratings for NXEN and its competitors with MarketBeat's FREE daily newsletter.

Nexien BioPharma (OTCMKTS:NXEN) Frequently Asked Questions

What stocks does MarketBeat like better than Nexien BioPharma?

Wall Street analysts have given Nexien BioPharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nexien BioPharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nexien BioPharma?

Nexien BioPharma saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 7,000 shares, an increase of 55.6% from the January 28th total of 4,500 shares. Based on an average daily trading volume, of 47,300 shares, the short-interest ratio is presently 0.1 days.
View Nexien BioPharma's Short Interest.

Who are Nexien BioPharma's key executives?

Nexien BioPharma's management team includes the following people:

Mr. Richard S. Greenberg, Founder, CEO, Exec. VP & Chairman (Age 72)
Mr. Evan L. Wasoff CPA, Chief Financial Officer (Age 73)
Mr. Robert I. Goldfarb J.D., Esq., Chief Operating Officer (Age 65)
Dr. Linda Klumpers Ph.D., Consultant
Mr. Joseph Morgan, Consultant
Mr. Paul Wilkenson Ph.D., Consultant

Who are some of Nexien BioPharma's key competitors?

Some companies that are related to Nexien BioPharma include Acer Therapeutics (ACER), NovaBay Pharmaceuticals (NBY), Neos Therapeutics (NEOS), Alimera Sciences (ALIM), Generex Biotechnology (GNBT), Millendo Therapeutics (MLND), Panbela Therapeutics (PBLA), Phio Pharmaceuticals (PHIO), Sonnet BioTherapeutics (SONN), China Pharma (CPHI), Immuron (IMRN), InMed Pharmaceuticals (INM), F-star Therapeutics (FSTX), Predictive Technology Group (PRED) and GT Biopharma (GTBP).
View all of NXEN's competitors.

What is Nexien BioPharma's stock symbol?

Nexien BioPharma trades on the OTCMKTS under the ticker symbol "NXEN."

How do I buy shares of Nexien BioPharma?

Shares of NXEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nexien BioPharma's stock price today?

One share of NXEN stock can currently be purchased for approximately $0.19.

How much money does Nexien BioPharma make?

Nexien BioPharma has a market capitalization of $10.35 million.

What is Nexien BioPharma's official website?

The official website for Nexien BioPharma is www.nexienbiopharma.com.

Where are Nexien BioPharma's headquarters?

Nexien BioPharma is headquartered at 4340 East Kentucky Avenue Suite 206, Glendale CO, 80246.

How can I contact Nexien BioPharma?

Nexien BioPharma's mailing address is 4340 East Kentucky Avenue Suite 206, Glendale CO, 80246. The company can be reached via phone at 303-495-7583 or via email at [email protected]

This page was last updated on 3/7/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here